» Articles » PMID: 28405703

Metabolic Syndrome Contributes to Renal Injury Mediated by Hyperoxaluria in a Murine Model of Nephrolithiasis

Overview
Journal Urolithiasis
Publisher Springer
Specialty Urology
Date 2017 Apr 14
PMID 28405703
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Metabolic syndrome (MS) individuals have a higher risk of developing chronic kidney disease through unclear pathogenic mechanisms. MS has been also related with higher nephrolithiasis prevalence. To establish the influence of MS on renal function, we designed a murine model of combined metabolic syndrome and hyperoxaluria. Four groups of male Sprague-Dawley rats were established: (1) control group (n = 10) fed with standard chow; (2) stone former group (SF) (n = 10) fed with standard chow plus 0.75% ethylene glycol administered in the drinking water; (3) metabolic syndrome group (MS) (n = 10), fed with 60% fructose diet; (4) metabolic syndrome + stone former group (MS + SF) (n = 10), 60% fructose diet and 0.75% EG in the drinking water. MS group showed a significant injury to renal function when hyperoxaluria was induced. It was demonstrated by a significant decrease of creatinine clearance (p < 0.001), with higher tubular damage (34.3%, CI 95% 23.9-44.7, p < 0.001), produced by deposition of crystals, and increased tubular synthesis of osteopontin as a response to tubular damage. Induction of hyperoxaluria in rats with MS causes severe morphological alterations with a significant impairment of renal function. This impairment is not produced in rats without MS. Therefore, this model can be useful for the study of the influence of MS in stone formation.

Citing Articles

Association between atherosclerosis and the development of multi-organ pathologies.

Dabravolski S, Churov A, Elizova N, Ravani A, Karimova A, Sukhorukov V SAGE Open Med. 2024; 12:20503121241310013.

PMID: 39734765 PMC: 11672402. DOI: 10.1177/20503121241310013.


Association between triglyceride-glucose index and risk of kidney stone: a Chinese population-based case-control study.

Wang D, Zhang D, Zhang L, Shi F, Zhu Y BMJ Open. 2024; 14(11):e086641.

PMID: 39578031 PMC: 11590796. DOI: 10.1136/bmjopen-2024-086641.


Hospitalization Burden of Patients with Kidney Stones and Metabolic Comorbidities in Spain during the Period 2017-2020.

Saenz-Medina J, San Roman J, Rodriguez-Monsalve M, Duran M, Carballido J, Prieto D Metabolites. 2023; 13(4).

PMID: 37110232 PMC: 10142441. DOI: 10.3390/metabo13040574.


Hyperoxaluria Induces Endothelial Dysfunction in Preglomerular Arteries: Involvement of Oxidative Stress.

Saenz-Medina J, Munoz M, Rodriguez C, Contreras C, Sanchez A, Coronado M Cells. 2022; 11(15).

PMID: 35954150 PMC: 9367519. DOI: 10.3390/cells11152306.


A pilot dynamic analysis of formative factors of nephrolithiasis related to metabolic syndrome: evidence in a rat model.

He Q, Tang Y, Li Y, Wang F, Bao J, Gupta S Ren Fail. 2022; 44(1):1134-1143.

PMID: 35837686 PMC: 9291672. DOI: 10.1080/0886022X.2022.2097922.


References
1.
Unger R . Lipotoxic diseases. Annu Rev Med. 2002; 53:319-36. DOI: 10.1146/annurev.med.53.082901.104057. View

2.
Coe F, STRAUSS A, Tembe V, Le Dun S . Uric acid saturation in calcium nephrolithiasis. Kidney Int. 1980; 17(5):662-8. DOI: 10.1038/ki.1980.205. View

3.
Tiselius H, Berg C, Fornander A, Nilsson M . Effects of citrate on the different phases of calcium oxalate crystallization. Scanning Microsc. 1993; 7(1):381-9; discussion 389-90. View

4.
Rendina D, Mossetti G, DE Filippo G, Benvenuto D, Vivona C, Imbroinise A . Association between metabolic syndrome and nephrolithiasis in an inpatient population in southern Italy: role of gender, hypertension and abdominal obesity. Nephrol Dial Transplant. 2008; 24(3):900-6. DOI: 10.1093/ndt/gfn548. View

5.
Guize L, Thomas F, Pannier B, Bean K, Danchin N, Benetos A . [Metabolic syndrome: prevalence, risk factors and mortality in a French population of 62 000 subjects]. Bull Acad Natl Med. 2006; 190(3):685-97. View